Evidence map›Paper›PMID 38658105›Full record

ArticleJournal of the American College of Cardiology2024

Permanent Pacemaker Implantation and Long-Term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve Surgery.

Alexander Iribarne, Sundos H Alabbadi, Alan J Moskowitz, Gorav Ailawadi, Vinay Badhwar, Marc Gillinov, Vinod H Thourani, Keith B Allen, Michael E Halkos, Nirav C Patel and 15 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. 2025 ESC/EACTS valvular heart disease guidelines: practical updates on mitral and tricuspid regurgitation.European heart journal supplements : journal of the European Society of Cardiology · 2026
    Article
  2. Article
  3. Review
  4. Permanent pacemaker implantation following mitral valve surgery. State-of-the-art scoping review.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 16 institutions in 3 countries.

Alexander IribarneDepartment of Cardiothoracic Surgery, Staten Island University Hospital, Northwell Health, Staten Island, New York, USA.
Sundos H AlabbadiGraduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Alan J MoskowitzPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Gorav AilawadiCardiac Surgery, Frankel Cardiovascular Center, University of Michigan Health System, Ann Arbor, Michigan, USA.
Vinay BadhwarDepartment of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, West Virginia, USA.
Marc GillinovDepartment of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
Vinod H ThouraniDepartment of Cardiovascular Surgery, Marcus Valve Center, Piedmont Heart Institute, Atlanta, Georgia, USA.
Keith B AllenDepartment of Cardiothoracic and Vascular Surgery, St Luke's Hospital, St Luke's Mid America Heart Institute, Kansas City, Missouri, USA.
Michael E HalkosDivision of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Nirav C PatelDepartment of Cardiovascular and Thoracic Surgery, Lenox Hill Hospital/Northwell Health, New York, New York, USA.
Robert S KramerDivision of Cardiovascular Surgery, Maine Medical Center, Portland, Maine, USA.
David D'AlessandroDivision of Cardiac Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Samantha RaymondPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Helena L ChangPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Lopa GuptaPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Kathleen N FentonDivision of Cardiovascular Sciences, National Heart. Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Wendy C Taddei-PetersDivision of Cardiovascular Sciences, National Heart. Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Michael W A ChuDivision of Cardiac Surgery, Western University, London Health Sciences Centre, London, Ontario, Canada.
Volkmar FalkDepartment of Cardiothoracic and Vascular Surgery, Deutsche Herzzentrum Berlin, Berlin, Germany; Department of Cardiovascular Surgery, Charité Universitätsmedizin Berlin, Berlin, Germany; German Centre for Cardiovascular Research, DZHK, Partner Site Berlin, Berlin, Germany.
Joanna ChikweDepartment of Cardiac Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Neal JeffriesOffice of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
Emilia BagiellaPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Patrick T O'GaraCardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Annetine C GelijnsPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: annetine.gelijns@mssm.edu.
Natalia N EgorovaPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Icahn School of Medicine at Mount Sinai · USNational Heart Lung and Blood Institute · USCedars-Sinai Medical Center · USCleveland Clinic · USEmory University · USGerman Centre for Cardiovascular Research · DELenox Hill Hospital · USMaine Medical Center · USMassachusetts General Hospital · USMichigan Medicine · USNational Institutes of Health · USNorthwell Health · USSt. Luke's Hospital · USValve (United States) · USWestern University · CAWest Virginia University · US

Funding

REVISED CAROL ACT IIU01HL088942 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GELIJNS, ANNE CHRISTINE, MOSKOWITZ, ALAN J · 2007 to 2025
$122.6M
NHLBI NIH HHS U01 HL088942
6 · The paper itself

Abstract

backgroundTricuspid valve annuloplasty (TA) during mitral valve repair (MVr) is associated with increased risk of permanent pacemaker (PPM) implantation, but the magnitude of risk and long-term clinical consequences have not been firmly established.

objectivesThis study assesses the incidence rates of PPM implantation after isolated MVr and following MVr with TA as well as the associated long-term clinical consequences of PPM implantation.

methodsState-mandated hospital discharge databases of New York and California were queried for patients undergoing MVr (isolated or with concomitant TA) between 2004 and 2019. Patients were stratified by whether or not they received a PPM within 90 days of index surgery. After weighting by propensity score, survival, heart failure hospitalizations (HFHs), endocarditis, stroke, and reoperation were compared between patients with or without PPM.

resultsA total of 32,736 patients underwent isolated MVr (n = 28,003) or MVr + TA (n = 4,733). Annual MVr + TA volumes increased throughout the study period (P < 0.001, trend), and PPM rates decreased (P < 0.001, trend). The incidence of PPM implantation <90 days after surgery was 7.7% for MVr and 14.0% for MVr + TA. In 90-day conditional landmark-weighted analyses, PPMs were associated with reduced long-term survival among MVr (HR: 1.96; 95% CI: 1.75-2.19; P < 0.001) and MVr + TA recipients (HR: 1.65; 95% CI: 1.28-2.14; P < 0.001). In both surgical groups, PPMs were also associated with an increased risk of HFH (HR: 1.56; 95% CI: 1.27-1.90; P < 0.001) and endocarditis (HR: 1.95; 95% CI: 1.52-2.51; P < 0.001), but not with stroke or reoperation.

conclusionsCompared to isolated MVr, adding TA to MVr was associated with a higher risk of 90-day PPM implantation. In both surgical groups, PPM implantation was associated with an increase in mortality, HFH, and endocarditis.

Indexed as

Pacemaker, ArtificialTricuspid ValveAgedCardiac Valve AnnuloplastyFemaleHumansMaleMiddle AgedMitral ValvePostoperative ComplicationsRetrospective StudiesTreatment Outcomeheart failure hospitalizationsmitral valve repairmortalitytricuspid annuloplasty

Identifiers

PMID38658105
PMCPMC11844026
OpenAlexW4395014831

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.